SCHEMBL26802242

SCHEMBL26802242

COC(=O)Oc1ccc2nc(C(C)=O)ccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 3/20 0.45
▸ HDAC6 Q9UBN7 3/20 0.45
▸ HDAC2 Q92769 2/20 0.45
▸ HDAC3 O15379 1/20 0.45
▸ HDAC4 P56524 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC7 Q8WUI4 1/20 0.45
▸ HDAC10 Q969S8 1/20 0.45
▸ HDAC11 Q96DB2 1/20 0.45
▸ HDAC9 Q9UKV0 1/20 0.45
▸ HDAC5 Q9UQL6 1/20 0.45
▸ SCN9A Q15858 12/20 0.43
▸ SCN7A Q01118 1/20 0.43
▸ KCNH2 Q12809 1/20 0.43
▸ PDE3B Q13370 1/20 0.42
▸ PDE3A Q14432 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ F2 P00734 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26824311 0.85 SCN9A (0.42) HDAC8HDAC6HDAC2HDAC3HDAC4
SCHEMBL23751547 0.84 HDAC8 (0.56) HDAC8HDAC6HDAC2HDAC3HDAC4
SCHEMBL2944091 0.80 KDM4E (0.47) ALDH1A1
SCHEMBL26802238 0.76 KDM4E (0.50) ALDH1A1HPGD
SCHEMBL2494747 0.75 ALDH1A1 (0.72) ALDH1A1F2GLAHPGD
SCHEMBL7180001 0.74 KDM4E (0.46) ALDH1A1GLAHPGD
SCHEMBL14514195 0.74 KMT2A (0.58) ALDH1A1
SCHEMBL7342388 0.74 HDAC8 (0.55) HDAC8HDAC6HDAC2HDAC3HDAC4
SCHEMBL12849492 0.73 CNR2 (0.51) HDAC8HDAC6HDAC2HDAC3HDAC4
SCHEMBL6509388 0.73 KMT2A (0.51) ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381327-A1 REACTIVE CONJUGATES DEBIOPHARM RESEARCH & MANUFACTURING S.A. (CH) 2023-11-30 — — US disclosed
US-20230381327-A1 REACTIVE CONJUGATES DEBIOPHARM RESEARCH & MANUFACTURING S.A. (CH) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381327-A1 REACTIVE CONJUGATES FCGR3B, FCGR1A, FCGR2A HDAC8 3129/4885HDAC6 32/4885HDAC2 1484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback